ARCHIVES

NTP Board Approves Concept For New Mutagenesis Assays

This article is from The Cancer Letter archive.

Vol. 14 No. 01 | January 1, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Kovac, Bunn Lead AACI; Hollings Researcher Wins Immunology Award; Turrisi Moves To SC

September 16, 1994

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

Funding Mechanisms: How They Are Used

August 12, 1983

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010